Knowledge and adherence to antiretroviral therapy among adult people living with HIV/AIDS treated in the health care centers of the association "Espoir Vie Togo" in Togo, West Africa

BMC Clinical Pharmacology

Volumn 10, Issue , 2010, Pages

  Potchoo, Yao ^a   Tchamdja, Kpatcha ^b   Balogou, Agnon ^a   Pitche, Vincent P ^a   Guissou, Innocent P ^c   Kassang, Etienne K ^d  

^a UNIVERSITY OF LOMÉ   (Togo)

^b Centre hospitalier universitaire de Kara   (Togo)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d Région Centrale ^*  (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; INDINAVIR; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NELFINAVIR; STAVUDINE; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DRUG COST; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; SELF REPORT; STRUCTURED QUESTIONNAIRE; TOGO; TRAVEL; UNSPECIFIED SIDE EFFECT; COMPREHENSION; DRUG ADMINISTRATION; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HEALTH SERVICE; MIDDLE AGED; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ADULT; ANTI-RETROVIRAL AGENTS; COMPREHENSION; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROGRAM EVALUATION; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TOGO; TRAVEL; URBAN HEALTH SERVICES; YOUNG ADULT;

EID: 77957350607     PISSN: None     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-10-11     Document Type: Article

References (36)

1. Katlama C, Pialoux G, Girard PM. Traitements antirétroviraux. VIH 2004, 299-329. Paris: Doin, Girard PM, Katlama C, Pialoux G.
2. Fonquerine L, Girard PM. Classification, définitions et facteurs prévisionnels d'évolution de l'infection VIH-1 chez l'adulte. VIH 2004, 53-63. Paris: Doin, Girard PM, Katlama C, Pialoux G.
3. McDonnell Holstatd MK, Pace JC, De AK, Ura DR. Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care 2006, 17(2):4-15. 10.1016/j.jana.2006.01.002, 16800163.
4. Spire B. Problèmes cliniques et comportementaux liés à la chronicisation de la maladie. Le SIDA 20 ans après: d'une maladie mortelle à une maladie chronique. Actualité et Dossier de Santé Publique 2002, 09:23-25.
5. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Social Science & Medicine 2000, 50:1599-1605.
6. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Smith N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000, 133(Suppl 1):21-30.
7. Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. Journal of Acquired Immune Deficiency Syndrome 2002, 31(Suppl 2):S103-S106.
8. Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation behavioral skills model of adherence to antiretroviral therapy. Health Psychology 2006, 25(4):462-473. 10.1037/0278-6133.25.4.462, 16846321.
9. Jones DL, McPherson-Baker S, Lydston D, Camille J, Brondolo E, Tobin JN, Weiss SM. Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women: The SMART/EST Women's Project. AIDS Behav 2007, 11:79-86. 10.1007/s10461-006-9165-8, 2525666, 17028992.
10. Stone VE, Hogan JW, Schuman P, Rompalo AM, Howard AA, Korkontzelou C, Smith DK. Antiretroviral regimen complexity, self-reported adherence, and HIV patient's understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndrome 2001, 28(Suppl 2):124-131.
11. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Minh Le G. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior 2003, 7(suppl 1):61-72. 10.1023/A:1022513507669, 14534391.
12. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York city. Aids Patient Care and STDs 2002, 16(Suppl 9):431-439. 10.1089/108729102760330272, 12396695.
13. Goujard C, Bernard N, Sohier N, Peyramond D, Lancon F, Chwalow J, Arnould B, Delfraissy J-F. Impact of a patient education program on adherence to HIV medication: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndrome 2003, 34(Suppl 2):191-194.
14. Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, Jacobson M. "It's all the time my mind": Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Social Science & Medicine 2009, 68(10):1793-1800.
15. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogeyi R, Oyabba T, Temu F, Laing R. Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa. AIDS care-psychological and socio-medical aspects of AIDS/HIV 2007, 19(5):658-665.
16. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Robertson M, Zolopa AR, Moss A. Adherence to HAART predicts progressing to Aids. AIDS 2001, 15(9):1181-1183. 10.1097/00002030-200106150-00015, 11416722.
17. Programme National de Lutte contre le SIDA (PNLS-Togo) Evaluation de la prise en charge thérapeutique des personnes vivant avec le VIH (PVVIH) par les antirétroviraux (ARV) au Togo. 2005, 1-24. Programme National de Lutte contre le SIDA (PNLS-Togo).
18. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004, 18(suppl 3):S27-S31. 10.1097/00002030-200406003-00006, 15322481.
19. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007, 21(8):965-971. 10.1097/QAD.0b013e32802e6bfa, 17457090.
20. Etard J-F, Lanièce I, Fall MBK, Cilote V, Blazejewski L, Diop K, Desclaux A, Ecochard R, Ndoye I, Delaporte E, . ANRS 1215/1290 Study Group A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients. Tropical Medicine and International Health 2007, 12(10):1191-1198. 10.1111/j.1365-3156.2007.01910.x, 17956501, ANRS 1215/1290 Study Group.
21. Laniece I, Desclaux A, Ciss M, Diop K, Ndiaye B. L'observance des traitements antirétroviraux et ses déterminants. Analyse quantitative. L'initiative sénégalaise d'accès aux médicaments antirétroviraux 2002, 97-108. Paris ANRS, Desclaux A, Laniece I, Ndoye I.
22. Benjaber K, Rey JL, Himmich H. Etude sur l'observance du traitement antirétroviral à Casablanca. Médecine et maladies infectieuses 2005, 35:390-395.
23. Roux P, Rey JL, Sehonou J, Certain A. L'observance à un mois des patients sida inclus dans l'initiative béninoise d'accès aux antirétroviraux. Bull Soc Pharm Bordeaux 2004, 143:19-30.
24. Zachariah R, Van Engelgem I, Massaquoi M, Kocholla L, Manzi M, Suleh A, Phillips M, Borgdorff M. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008, 102:288-293. 10.1016/j.trstmh.2007.12.007, 18258272.
25. Vriesendorp R, Cohen A, Kristanto P, Vriejens B, Rakesh P, Anand B, Iwebor HU, Stiekema J. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol 2007, 63:1115-1121. 10.1007/s00228-007-0369-2, 2071959, 17882408.
26. Diabate S, Alery M, Koffi CK. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire. AIDS 2007, 21(13):1799-1803. 10.1097/QAD.0b013e3282a5667b, 17690579.
27. Sethi AK, Celantano DD, Gange SF, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003, 37:1112-1118. 10.1086/378301, 14523777.
28. Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis 2005, 40:158-163. 10.1086/426595, 15614706.
29. Bangsberg DR. Less than 95% adherence to nucleoside reverse-transcriptase inhibitors therapy can lead to viral suppression. Clin Infect Dis 2006, 43:939-941. 10.1086/507526, 16941380.
30. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstracts reports. Patient Education and Counselling 2001, 46(2):93-108.
31. Laniece I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, Sylla O, Delaporte E, Ndoye I. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003, 17(suppl 3):S103-S108. 10.1097/00002030-200317003-00014, 14565616.
32. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilberg P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003, 34(3):281-288. 10.1097/00126334-200311010-00004, 14600572.
33. Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, Tichacek A, Allen SA. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda [Letter]. AIDS 2006, 20(16):2116-2118. 10.1097/01.aids.0000247580.16073.1b, 17053359.
34. Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV. Symptoms experienced by HIV-infected individuals on antiretroviral therapy in Kwazulu-Natal, South Africa. Applied Nursing Research Correct Proof 2009.
35. McDonnell Holstatd MK, Pace JC, De AK, Ura DR. Factors associated with adherence to antiretroviral therapy. Journal of the Association of Nurses in AIDS Care 2006, 17(2):4-15. 10.1016/j.jana.2006.01.002, 16800163.
36. Salmon-Ceron D, Deleuze J, Coste J, Guerin C, Guinburg C, Blanche P, Finkielsztejn L, Pecqueux L, Chaput S, Gorin I, Sicard D. Enquête sur l'observance des traitements antirétroviraux comportant un inhibiteur de protéase chez des patients infectés par le VIH. Paris, Masson 2000, 297-302.